Awards & Advancement

Miclot joins Tengion

Tuesday, December 6, 2011 09:25 AM

Tengion has named John L. Miclot president and chief executive officer.

More... »

BioNano names Monroe CFO

Monday, December 5, 2011 02:57 PM

BioNano Genomics has named Garth Monroe chief financial officer. Monroe will report to president and chief executive officer Dr. R. Erik Holmlin.

More... »

Alexian Brothers Health System names president and CEO

Monday, December 5, 2011 09:48 AM

Mark A. Frey has been named president and chief executive officer of the Alexian Brothers Health System. He succeeds Brother Thomas Keusenkothen, C.F.A., who retired from the position on December 1, 2011.

More... »

Heffelfinger joins PrimeraDx

Thursday, December 1, 2011 02:53 PM

PrimeraDx has named David Heffelfinger vice president of engineering and systems development.

More... »

arGEN-X raises $37m in Series B financing

Thursday, December 1, 2011 02:18 PM

arGEN-X has closed a $37 million Series B fundraising round, which was oversubscribed. The fundraising was co-led by OrbiMed Advisors (USA) and Seventure Partners (France), with the existing shareholders Forbion Capital Partners, Credit Agricole Private Equity, LSP, BioGeneration Ventures, the Erasmus Biomedical Fund, Thuja Capital and VIB also participating. OrbiMed's founding partner, Dr Mike Sheffery, will join the arGEN-X Supervisory Board.

More... »

Galleon names Brookes senior VP

Thursday, December 1, 2011 11:38 AM

Galleon Pharmaceuticals has named Lynne M. Brookes senior vice president and chief business officer.

More... »

Mirani joins DaVita Labs

Thursday, December 1, 2011 10:43 AM

More... »

Rhythm names chief scientific officer

Wednesday, November 30, 2011 12:40 PM

Rhythm has named Lex Van der Ploeg, PhD, chief scientific officer. Van der Ploeg brings to Rhythm more than 25 years of drug development experience in obesity, metabolic diseases, and other therapeutic areas.

More... »

GenturaDx names scientific advisory board

Tuesday, November 29, 2011 11:51 AM

GenturaDx has created its scientific advisory board with three initial members: Dr. Keith Jerome, Dr. Steven Miller, and Dr. Gregory Tsongalis. The board will provide expert perspectives across science, laboratory medicine and the commercial market related to initial test development and future applications of the company's proprietary IDbox(TM). The IDbox system is set to begin clinical trials in 2012.

More... »

Tang joins ICON Development Solutions

Monday, November 28, 2011 11:29 AM

ICON's Development Solutions division has named Dr. Daniel Tang general manager, Asia Pacific. Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.

More... »